Related Experiment Videos
Low back pain during streptokinase infusion
Ronald Feitosa Pinheiro1, Adriana Sanches Pedrolo, Marcelo Nigri
1Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Arquivos Brasileiros De Cardiologia
|March 12, 2002
Summary
A patient experienced severe low back pain during streptokinase infusion for chest pain. This case highlights the importance of considering this adverse event in differential diagnoses.
Area of Science:
- Cardiology
- Pharmacology
- Pain Management
Background:
- ST-elevation myocardial infarction (STEMI) requires timely reperfusion therapy.
- Streptokinase is a thrombolytic agent used to treat acute myocardial infarction.
- Adverse events associated with thrombolytic therapy require careful monitoring and management.
Observation:
- A 57-year-old male presented with typical chest pain and inferior wall ST-segment elevation, indicative of acute myocardial infarction.
- During intravenous streptokinase infusion for reperfusion therapy, the patient developed severe low back pain.
- This symptom was unexpected and prompted further investigation.
Findings:
- The occurrence of severe low back pain during streptokinase infusion is a rare but significant adverse event.
- Differential diagnosis for this symptom includes non-cardiac causes and referred pain.
- Pathophysiological mechanisms may involve direct effects of the drug or systemic inflammatory responses.
Implications:
- Clinicians should be aware of severe low back pain as a potential side effect of streptokinase.
- Prompt recognition and evaluation are crucial for appropriate patient management.
- Further research into the pathophysiology and incidence of this adverse event is warranted.